The study also identified factors related to the outcome of treatment, such as the relationship between the decrease in PSA and the clinical features (age, Gleason score, partial prostate surgery) and factors related to survival time such as age, neutrophil count, PSA nadir <0.2 ng / ml, time to PSA nadir, testosteron level during ADT treatment time.